NICOLE PAYNE: Open Payments
NPI 1851575138 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 90 payments from 19 companies in 2025. Trend: 2023 $1,092 · 2024 $1,614 · 2025 $1,617
Food & beverage: $1,617
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $384 |
| ABBVIE INC. | 26 | $258 |
| Lilly USA, LLC | 17 | $239 |
| AstraZeneca Pharmaceuticals LP | 8 | $165 |
| Janssen Pharmaceuticals, Inc | 2 | $149 |
| Boston Scientific Corporation | 2 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Amgen Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
| Electromed, Inc. | 2 | $37 |
Products named: MOUNJARO, UBRELVY, AIRSUPRA, SPRAVATO, Ozempic, Wegovy, Saxenda, JARDIANCE.
Industry payments across MS — which companies pay providers there.
